Literature DB >> 12615196

Cytokine-induced sickness behavior.

Keith W Kelley1, Rose-Marie Bluthé, Robert Dantzer, Jian-Hua Zhou, Wen-Hong Shen, Rodney W Johnson, Suzanne R Broussard.   

Abstract

The behavioral repertoire of humans and animals changes dramatically following infection. Sick individuals have little motivation to eat, are listless, complain of fatigue and malaise, loose interest in social activities and have significant changes in sleep patterns. They display an inability to experience pleasure, have exaggerated responses to pain and fail to concentrate. Proinflammatory cytokines acting in the brain cause sickness behaviors. These nearly universal behavioral changes are a manifestation of a central motivational state that is designed to promote recovery. Exaggerated symptoms of sickness in cancer patients, such as cachexia, can be life-threatening. However, quality of life is often drastically impaired before the cancer becomes totally debilitating. Although basic studies in psychoneuroimmunology have defined proinflammatory cytokines as the central mediators of sickness behavior, a much better understanding of how cytokine and neurotransmitter receptors communicate with each other is needed. Advances that have been made during the past decade should now be extended to clinical studies in an attempt to alleviate sickness symptoms and improve quality of life for cancer patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615196     DOI: 10.1016/s0889-1591(02)00077-6

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  205 in total

1.  Continuous stress disrupts immunostimulatory effects of IL-12.

Authors:  Ben Levi; Marganit Benish; Yael Goldfarb; Liat Sorski; Rivka Melamed; Ella Rosenne; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2011-01-28       Impact factor: 7.217

2.  Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.

Authors:  Lianqi Liu; Paul J Mills; Michelle Rissling; Lavinia Fiorentino; Loki Natarajan; Joel E Dimsdale; Georgia Robins Sadler; Barbara A Parker; Sonia Ancoli-Israel
Journal:  Brain Behav Immun       Date:  2012-03-02       Impact factor: 7.217

Review 3.  Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier.

Authors:  Michelle A Erickson; Kenji Dohi; William A Banks
Journal:  Neuroimmunomodulation       Date:  2012-01-11       Impact factor: 2.492

4.  A perception theory in mind-body medicine: guided imagery and mindful meditation as cross-modal adaptation.

Authors:  Felice L Bedford
Journal:  Psychon Bull Rev       Date:  2012-02

5.  Challenges in addressing depression in HIV research: assessment, cultural context, and methods.

Authors:  Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson
Journal:  AIDS Behav       Date:  2011-02

6.  Sleep dysfunction in patients with cancer.

Authors:  Lavinia Fiorentino; Sonia Ancoli-Israel
Journal:  Curr Treat Options Neurol       Date:  2007-09       Impact factor: 3.598

7.  A role for orexin in cytotoxic chemotherapy-induced fatigue.

Authors:  K B Weymann; L J Wood; X Zhu; D L Marks
Journal:  Brain Behav Immun       Date:  2013-11-09       Impact factor: 7.217

Review 8.  Getting nervous about immunity.

Authors:  Keith W Kelley; Robert H McCusker
Journal:  Semin Immunol       Date:  2014-02-18       Impact factor: 11.130

9.  Prostaglandins mediate zymosan-induced sickness behavior in mice.

Authors:  Juliana B M Lima; Clarice C Veloso; Fabiana C Vilela; Alexandre Giusti-Paiva
Journal:  J Physiol Sci       Date:  2016-10-03       Impact factor: 2.781

10.  Cytokine regulation of tryptophan metabolism in the hypothalamic-pituitary-adrenal (HPA) axis: implications for protective and toxic consequences in neuroendocrine regulation.

Authors:  Huolin Tu; Peter L Rady; Terry Juelich; Eric M Smith; Stephen K Tyring; Thomas K Hughes
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.